Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI PET/CT in Myositis
NCT05952531Phase 1Unknown
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- Jul 2023
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by First Affiliated Hospital of Xiamen University. Primary endpoint: Distribution pattern of 68Ga-FAPI in patients with IIM at 60 minutes. Status: unknown.
Beyond the preview
Go deeper on NCT05952531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05952531.